NCT04985357 2024-11-25
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
Withdrawn
Travera Inc
National Institutes of Health Clinical Center (CC)
Yale University
Sanofi
Case Comprehensive Cancer Center